Rosen Law Firm Investigates Claims Against Disc Medicine, Inc.
Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. The investigation centers on allegations that the company may have issued materially misleading or false information to investors.
NEW YORK – August 26, 2026 – Rosen Law Firm, a global investor rights law firm, is continuing its investigation into potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON).
The investigation stems from allegations that Disc Medicine may have issued materially misleading or false information to investors. Specifically, the firm is examining disclosures made by the company regarding its business and financial performance.
Investors who have incurred losses on their IRON shares and wish to learn more about their rights are encouraged to contact Rosen Law Firm. The firm requests that investors provide details about any information they received that may have been materially inaccurate.
Rosen Law Firm has a history of successfully prosecuting securities class actions and aims to determine if the management of Disc Medicine engaged in practices that violated securities laws, causing harm to its shareholders.